Maculaser has been granted a Japanese patent for its method and device for determining changes in retinal and/or brain temperature. This is Maculaser’s first patent outside the EU and US and marks a significant milestone for the company. The newly granted patent, JP 7475071 B2, strengthens the protection of Maculaser’s primary treatment facilitator, retinal temperature control. Currently, Maculaser holds a total of five patent families with granted patents.
Maculaser’s solution employs retinal temperature monitoring designed to ensure safe, effective, and consistent treatments for every patient. It takes into account inter-patient variability and differences across retinal locations.
